Comments
Loading...

Talis Biomedical Analyst Ratings

TLISOTCEM
Logo brought to you by Benzinga Data
$1.74
At close: Mar 21, 3:32 PM EDT
Consensus Rating1
Sell
Highest Price Target1
$5.00
Lowest Price Target1
$5.00
Consensus Price Target1
$5.00

Talis Biomedical Analyst Ratings and Price Targets | OTC:TLIS | Benzinga

Talis Biomedical Corp has a consensus price target of $5 based on the ratings of 1 analysts. The high is $5 issued by BTIG on August 16, 2023. The low is $5 issued by BTIG on August 16, 2023. The 1 most-recent analyst ratings were released by BTIG on August 16, 2023, respectively. With an average price target of $5 between BTIG, there's an implied 195.86% upside for Talis Biomedical Corp from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
2.0
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

BTIG

1calculated from analyst ratings

Analyst Ratings for Talis Biomedical

Buy NowGet Alert
08/16/2023Buy Now195.86%BTIG
Mark Massaro72%
$0.35 → $5MaintainsSellGet Alert

FAQ

Q

What is the target price for Talis Biomedical (TLIS) stock?

A

The latest price target for Talis Biomedical (OTCEM:TLIS) was reported by BTIG on August 16, 2023. The analyst firm set a price target for $5.00 expecting TLIS to rise to within 12 months (a possible 187.36% upside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Talis Biomedical (TLIS)?

A

The latest analyst rating for Talis Biomedical (OTCEM:TLIS) was provided by BTIG, and Talis Biomedical maintained their sell rating.

Q

When was the last upgrade for Talis Biomedical (TLIS)?

A

There is no last upgrade for Talis Biomedical

Q

When was the last downgrade for Talis Biomedical (TLIS)?

A

There is no last downgrade for Talis Biomedical.

Q

When is the next analyst rating going to be posted or updated for Talis Biomedical (TLIS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Talis Biomedical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Talis Biomedical was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.

Q

Is the Analyst Rating Talis Biomedical (TLIS) correct?

A

While ratings are subjective and will change, the latest Talis Biomedical (TLIS) rating was a maintained with a price target of $0.35 to $5.00. The current price Talis Biomedical (TLIS) is trading at is $1.74, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.